HAVCR2 and type 1 diabetes mellitus: In addition, both TIM-3 blocking antibody and TIM-3–Ig fusion protein exacerbate symptoms of EAE (5, 10, 11), type I diabetes in non-obese (NOD) mice (12), and acute graft-versus-host disease (aGVHD) (13, 14).